468 related articles for article (PubMed ID: 29686276)
1. Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel.
Yadlapati R; Vaezi MF; Vela MF; Spechler SJ; Shaheen NJ; Richter J; Lacy BE; Katzka D; Katz PO; Kahrilas PJ; Gyawali PC; Gerson L; Fass R; Castell DO; Craft J; Hillman L; Pandolfino JE
Am J Gastroenterol; 2018 Jul; 113(7):980-986. PubMed ID: 29686276
[TBL] [Abstract][Full Text] [Related]
2. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
Yadlapati R; Gyawali CP; Pandolfino JE;
Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
[TBL] [Abstract][Full Text] [Related]
3. Surgical and endoscopic management options for patients with GERD based on proton pump inhibitor symptom response: recommendations from an expert U.S. panel.
Gawron AJ; Bell R; Abu Dayyeh BK; Buckley FP; Chang K; Dunst CM; Edmundowicz SA; Jobe B; Lipham JC; Lister D; Canto MI; Smith MS; Starpoli AA; Triadafilopoulos G; Watson TJ; Wilson E; Pandolfino JE; Kaizer A; Van De Voorde Z; Yadlapati R
Gastrointest Endosc; 2020 Jul; 92(1):78-87.e2. PubMed ID: 32007519
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease.
Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND
Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768
[TBL] [Abstract][Full Text] [Related]
5. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
[TBL] [Abstract][Full Text] [Related]
6. Review of antireflux procedures for proton pump inhibitor nonresponsive gastroesophageal reflux disease.
Hillman L; Yadlapati R; Whitsett M; Thuluvath AJ; Berendsen MA; Pandolfino JE
Dis Esophagus; 2017 Sep; 30(9):1-14. PubMed ID: 28859357
[TBL] [Abstract][Full Text] [Related]
7. Nissen fundoplication
Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic Hiatal Hernia Repair Followed by Transoral Incisionless Fundoplication With EsophyX Device (HH + TIF): Efficacy and Safety in Two Community Hospitals.
Janu P; Shughoury AB; Venkat K; Hurwich D; Galouzis T; Siatras J; Streeter D; Korman K; Mavrelis G; Mavrelis P
Surg Innov; 2019 Dec; 26(6):675-686. PubMed ID: 31431138
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of transoral fundoplication for treatment of chronic gastroesophageal reflux disease incompletely controlled with high-dose proton-pump inhibitors therapy: a randomized, multicenter, open label, crossover study.
Trad KS; Simoni G; Barnes WE; Shughoury AB; Raza M; Heise JA; Turgeon DG; Fox MA; Mavrelis PG
BMC Gastroenterol; 2014 Oct; 14():174. PubMed ID: 25284142
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic Hiatal Hernia Repair With Concomitant Transoral Incisionless Fundoplication.
Pype DL
AORN J; 2023 Mar; 117(3):149-158. PubMed ID: 36825913
[TBL] [Abstract][Full Text] [Related]
11. Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm.
Trad KS; Fox MA; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Barnes WE
Surg Endosc; 2017 Jun; 31(6):2498-2508. PubMed ID: 27655380
[TBL] [Abstract][Full Text] [Related]
12. Endoluminal Therapy for Gastroesophageal Reflux Disease: In Between the Pill and the Knife?
Brar TS; Draganov PV; Yang D
Dig Dis Sci; 2017 Jan; 62(1):16-25. PubMed ID: 27796767
[TBL] [Abstract][Full Text] [Related]
13. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial.
Trad KS; Barnes WE; Simoni G; Shughoury AB; Mavrelis PG; Raza M; Heise JA; Turgeon DG; Fox MA
Surg Innov; 2015 Feb; 22(1):26-40. PubMed ID: 24756976
[TBL] [Abstract][Full Text] [Related]
14. Comparative Analysis of Laparoscopic Fundoplication and Magnetic Sphincter Augmentation for the Treatment of Medically Refractory GERD.
Richards WO; McRae C
Am Surg; 2018 Nov; 84(11):1762-1767. PubMed ID: 30747630
[TBL] [Abstract][Full Text] [Related]
15. Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring.
Frazzoni M; Conigliaro R; Melotti G
Dig Dis Sci; 2011 Apr; 56(4):1099-106. PubMed ID: 20737211
[TBL] [Abstract][Full Text] [Related]
16. Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients.
Testoni PA; Corsetti M; Di Pietro S; Castellaneta AG; Vailati C; Masci E; Passaretti S
World J Surg; 2010 Apr; 34(4):750-7. PubMed ID: 20091308
[TBL] [Abstract][Full Text] [Related]
17. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS?
Azzam RS
Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial.
Bell R; Lipham J; Louie B; Williams V; Luketich J; Hill M; Richards W; Dunst C; Lister D; McDowell-Jacobs L; Reardon P; Woods K; Gould J; Buckley FP; Kothari S; Khaitan L; Smith CD; Park A; Smith C; Jacobsen G; Abbas G; Katz P
Gastrointest Endosc; 2019 Jan; 89(1):14-22.e1. PubMed ID: 30031018
[TBL] [Abstract][Full Text] [Related]
19. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
[TBL] [Abstract][Full Text] [Related]
20. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
Beaumont H; Boeckxstaens GE
Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
